Search results
Vaccines deployed against triple viral threat from COVID-19, RSV, flu
Detroit Free Press via Yahoo News· 9 months agoNewly formulated COVID-19 vaccines won final approval from federal regulators Tuesday, giving...
California's COVID comeback intensifies, but officials say there's no cause for alarm
LA Times via Yahoo News· 9 months agoLunch time crowd at Grand Central Market in Los Angeles. Coronavirus levels have more than doubled...
The Most Common Questions About The Updated COVID Vaccine, Answered
HuffPost Life via Yahoo News· 2 years agoExperts break down the most important information on the new bivalent COVID-19 shots, which are now...
'Excess deaths' tied to COVID have plummeted in America — what does that mean?
Live Science via Yahoo News· 11 months agoA woman wearing blue latex gloves administering a vaccine to a man During the worst waves of the...
Pfizer Slashed Its Guidance, but Is It Still a Smart Long-Term Buy?
Motley Fool via Yahoo Finance· 6 months agoPer updated guidance for its upcoming 2024 fiscal year, issued on Dec. 13, Pfizer (NYSE: PFE) has a...
FDA to okay second omicron-targeting booster for some, officials say
Washington Post via Yahoo News· 1 year agoFederal regulators have decided to authorize a second omicron-specific coronavirus vaccine booster...
Where to get your COVID-19 bivalent booster vaccine in Michigan
Detroit Free Press via Yahoo News· 2 years agoThe newly authorized COVID-19 bivalent vaccine booster shots aimed at the BA.4 and BA.5 omicron...
Gap between tax expected and paid at £32bn in 2020/21 – HMRC
The Independent via Yahoo News· 2 years agoThe tax gap – the difference between the total amount of tax expected and that which is actually...
2 Stocks Down 36% or More to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 4 months agoThere's arguably no better time to buy a stock than when it's been beaten down. Doing so provides a...
Pfizer's Heading for a Patent Cliff. Is the Stock Still a Buy?
Motley Fool· 1 year agoThe company also continues to benefit from sales of blockbusters including blood thinner Eliquis and...